AQ BioPharma

company

About

AQ BioPharma is the first company in China to specialize in the research and development of fluorine-containing new drugs

  • 11 - 50

Details

Last Funding Type
Corporate Round
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Aq BioPharma is the first company in China to specialize in the research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates, and has opened up a new field of research and development of new fluorine-containing pharmaceuticals and fluorine-containing pharmaceutical intermediates in China. The company has 2,800 square meters of research and development and pilot bases and 50 acres of industrial base. After eight years of investment and development, more than 3,000 manufacturable products have been developed, of which 18 core process technologies and new drug research and development results have applied for invention patents. The company's main products include fluorine-containing pharmaceutical intermediates, piperidine, piperazine, pyrrolidine, azaindole, adamantane, aza-spiro, aza-cyclo.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
AQ BioPharma has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 1, 2019 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2019 Corporate Round 1 Chenghe Venture Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
AQ BioPharma is funded by 1 investors. Chenghe Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Chenghe Venture Capital Yes Corporate Round